The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

The National Reconstruction Fund Corporation (NRFC) has taken a $54 million stake in Australian medical device company Synchron, to support the production of minimally invasive Brain-Computer ...

A new report suggests Sam Altman is building a brain interface using sound waves, potentially rivaling Elon Musk’s Neuralink.

In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...

Sam Altman has tapped Mikhail Shapiro, an award-winning biomolecular engineer, to join the Merge Labs brain-computer ...

OpenAI CEO Sam Altman is reportedly launching Merge Labs, a new brain-computer interface startup, with biomolecular engineer ...